Need professional-grade analysis? Visit stockanalysis.com
$4.49M
N/A
2
N/A
PMHS (PMHS) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at $0.16.
Over the past year, PMHS has traded between a low of $0.07 and a high of $0.80. The stock has lost 59.0% over this period. It is currently 80.0% below its 52-week high.
PMHS has a market capitalization of $4.49M.
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
Side-by-side comparison against top Healthcare peers.